Tag: medical recall
Start your Oculentis claim today
If you’ve yet to start your Oculentis claim, here’s some information about getting started today. It’s important to claim as soon as you can.
If you’re one of the hundreds of people who have suffered with opacification problems having been fitted with intraocular lenses manufactured by Oculentis, you may have a claim for compensation. The blind spots and cloudiness in the vision can be caused by calcification from phosphate that was previously used in the manufacturing process.
The way to correct the problem is to have further surgery for the lenses to be replaced. You may be able to claim personal injury compensation for having to undergo the further surgical procedure.
Compensation action for victims of the Oculentis recall
If you’ve been affected by the Oculentis recall, you may be eligible to join our compensation action with No Win, No Fee representation.
If you’re one of the hundreds of people who have been affected by the opacification problems related to surgically-implanted intraocular lenses, we may be able to help you. If you’ve been suffering with blind spots ore cloudiness in your vision, and needed / need corrective surgery, you could be entitled to thousands of pounds in compensation.
Even if you didn’t have to pay for the revision surgery, you could still be eligible to make a claim. But hurry: time limits for these types of cases can lead to people missing out on their chance to make a claim.
Oculentis compensation action
If you’ve yet to initiate your legal action for Oculentis compensation, make sure you speak to our team as soon as you possibly can.
In this type of action, there can be complicated (and multiple) time limits to claim. Missing one or more of these deadlines could mean the difference between receiving thousands of pounds in compensation or getting absolutely nothing at all.
You may be eligible to claim Oculentis compensation if you’re one of the hundreds of people affected by the recall of their intraocular lenses.
Valsartan recall widens
The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).
Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases are already underway, and this latest recall involves further batches of the product.
An immediate suspension and quarantine of the additional affected products has been ordered.
Were you affected by the cough syrup mould recall?
Were you affected by the cough syrup mould issues that came to light over summer? In the midst of the season for colds and coughs, you may want to take heed of this warning if you’re not aware of it already.
Over summer, a formal recall was issued with the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency. This was a Class 2 Medicines recall for own-brand glycerine and blackcurrant cough syrup products manufactured for children by Bell, Sons & Co.
As these are marketed as own-brand products, it’s the likes of Asda, Morrisons, Sainsbury’s and Tesco at the centre of this recall.
Bone cement complications from product recall
A regulator warning earlier this year stemmed from bone cement complications caused by an issue with the product itself.
A risk of the need for revision surgery from the use of Optipac 40 Refobacin Revision and Optipac 80 Refobacin Revision was identified. Manufacturer, Biomet UK Limited, issued a Field Safety Notice at the end of last year. The UK’s medical regulator, the MHRA (Medicines and Healthcare products Regulatory Agency), issued their own recall advice off the back of the findings.
Anyone who has suffered with bone cement complications may find the reason is to do with the product itself as opposed to failed surgery.
Latanoprost Timolol eye drops recall
A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).
The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an ‘out of specification result for an unknown impurity’ that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.
The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.
Compensation for pelvic mesh problems
You can claim for personal injury compensation for pelvic mesh problems, and it’s important to claim given the severity of the issues that can arise.
We’ve spent a number of years talking about pelvic mesh problems, and we’re now at a point where the number of people suffering complications appears to be increasing, and people are far more aware of the dangers now. Only recently did the NHS finally put a widespread pause on the procedure – news we welcome – after another review into the safety and the efficacy of the devices.
With some victims left unable to walk or work for the rest of their lives, claiming compensation for personal injury and losses is incredibly important.
Phenytoin 90mg/5ml Oral Suspension immediate discontinuation
There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension and a recall of the product.
The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that the medication becomes difficult to resuspend over shelf-life.
Patients who use the Phenytoin 90mg/5ml Oral Suspension are being told to contact their doctors for more information and advice about the issues that have been identified.
Roche Diabetes Care test strip errors leads to recall
Roche Diabetes Care test strip errors has led to a recall of a number of home-use and point-of-care glucose monitoring systems.
The Roche Diabetes Care test strip errors are for the following systems: Accu-Chek Aviva; Accu-Chek Performa; and Accu-Chek Inform II.
There is a risk of a strip error message that may lead to either falsely high or falsely low blood glucose results reported.
Cancer drug recall confirmed by UK regulators
A cancer drug recall has been initiated due to reports of excessive levels of an active ingredient used in the drug.
Pharmaceutical company AstraZeneca UK has initiated the recall, primarily for batch NG327, because the “level of olaparib polymorphic form L exceeds the registered specification limit”.
As well as the batch being recalled above, there are other batches that are a part of the recall as well, which is all said to be a part of a precautionary measure.
Continue Reading…